Table 2.
Locoregional toxicity |
Pazopanib + RT | RT Alone | ||
---|---|---|---|---|
Grade 1-2 | Grade 3–5 | Grade 1-2 | Grade 3–5 | |
n affected (total) | n affected (total) | n affected (total) | n affected (total) | |
Fatigue | 12 (12) | 0 (12) | 25 (25) | 0 (25) |
Dermatitis radiation | 12 (12) | 0 (12) | 21 (19) | 4 (25) |
Skin hyperpigmentation | 2 (12) | 0 (12) | 15 (25) | 0 (25) |
Skin ulceration | 1 (12) | 0 (12) | 0 (25) | 0 (25) |
Soft tissue fibrosis | 0 (12) | 0 (12) | 0 (25) | 0 (25) |
Pneumonitis | 0 (12) | 0 (12) | 0 (25) | 0 (25) |
Diarrhea | 3 (12) | 0 (12) | 0 (25) | 0 (25) |
Hypertension | 1 (12) | 0 (12) | 0 (25) | 0 (25) |
Nausea | 2 (12) | 0 (12) | 0 (25) | 0 (25) |
Anorexia | 1 (12) | 1 (12) | 0 (25) | 0 (25) |
RT: radiotherapy; CTCAE: Common Terminology Criteria for Adverse Events (v4.0).